Scythian Biosciences Corp Stock Canadian Securities Exchange
Equities
CA7840531007
Investment Management & Fund Operators
Sales 2022 | -235.54 -321.47 | Sales 2023 | -31.51 -43.01 | Capitalization | 6.26M 8.55M |
---|---|---|---|---|---|
Net income 2022 | -297M -405M | Net income 2023 | -34M -46.4M | EV / Sales 2022 | -188,347 x |
Net Debt 2022 | 24.76M 33.8M | Net cash position 2023 | 70.4M 96.08M | EV / Sales 2023 | 2,035,264 x |
P/E ratio 2022 |
-0.07
x | P/E ratio 2023 |
-0.18
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.99% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Kania
CEO | Chief Executive Officer | - | 20-05-18 |
Deena Siblock
BRD | Director/Board Member | - | 23-02-26 |
Corporate Officer/Principal | - | 18-04-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mehdi Azodi
BRD | Director/Board Member | - | 23-02-26 |
Deena Siblock
BRD | Director/Board Member | - | 23-02-26 |
Jason Batista
BRD | Director/Board Member | - | 23-06-06 |
1st Jan change | Capi. | |
---|---|---|
+20.63% | 38.1B | |
0.00% | 19.95B | |
+5.03% | 5.44B | |
+5.62% | 3.29B | |
+20.28% | 2.86B | |
+8.84% | 2.82B | |
-15.62% | 2.4B | |
+3.52% | 1.23B | |
+9.65% | 1.22B |